Jin-Moo Lee Selected Research

25C-NBOH

2/2022

2-((2-(4-Iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol (25I-NBOH) and 2-(((2-(4-chloro-2,5-dimethoxyphenyl)ethyl)amino)methyl)phenol (25C-NBOH) induce adverse effects on the cardiovascular system.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jin-Moo Lee Research Topics

Disease

40	Stroke (Strokes) 01/2022 - 01/2002
22	Ischemic Stroke 01/2021 - 01/2002
19	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 01/2004
13	Amyloid Plaque 01/2022 - 01/2004
9	Infarction (Infarctions) 01/2022 - 02/2003
8	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 06/2021 - 09/2003
7	Sickle Cell Anemia (Hemoglobin S Disease) 01/2022 - 01/2018
6	Brain Injuries (Brain Injury) 01/2022 - 09/2006
6	Ischemia 01/2022 - 04/2003
6	Edema (Dropsy) 01/2022 - 01/2016
6	Neoplasms (Cancer) 10/2021 - 12/2019
6	Cerebral Hemorrhage 01/2020 - 12/2007
6	Hemorrhage 01/2020 - 09/2003
5	Inflammation (Inflammations) 01/2022 - 06/2015
4	Cardiotoxicity 03/2022 - 02/2020
4	Nervous System Diseases (Neurological Disorders) 01/2022 - 03/2008
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2021 - 01/2021
3	Brain Edema (Cerebral Edema) 01/2020 - 01/2016
3	Cold Hypersensitivity 04/2019 - 01/2017
2	Hypoxia (Hypoxemia) 01/2022 - 09/2012
2	Anemia 01/2022 - 10/2018
2	Hematoma 07/2021 - 01/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 01/2019
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 05/2011
2	Hypertension (High Blood Pressure) 01/2019 - 01/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2016 - 06/2010
2	Gliosis 06/2015 - 03/2008
2	Neuroblastoma 03/2015 - 01/2011
2	Carotid Stenosis (Carotid Artery Stenosis) 03/2014 - 01/2013
2	Dysmenorrhea (Menstrual Pain) 01/2014 - 06/2009
2	Diarrhea 01/2013 - 10/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2006 - 11/2005
1	Cardiac Arrhythmias (Arrythmia) 03/2022
1	Sickle Cell Trait 01/2022
1	Cerebral Small Vessel Diseases 01/2022
1	Disease Progression 01/2022
1	Fatigue 09/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 09/2021
1	Hyperhidrosis 09/2021
1	Carcinogenesis 05/2021
1	Breast Neoplasms (Breast Cancer) 04/2021
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2021
1	Cerebral Infarction 01/2021

Drug/Important Bio-Agent (IBA)

17	Oxygen (Dioxygen)IBA 01/2022 - 02/2003
13	Biomarkers (Surrogate Marker)IBA 01/2022 - 09/2006
13	Amyloid (Amyloid Fibrils)IBA 01/2022 - 10/2006
11	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2011
10	Amyloid beta-PeptidesIBA 07/2010 - 01/2004
8	Proteins (Proteins, Gene)FDA Link 04/2021 - 11/2005
7	Peptides (Polypeptides)IBA 06/2021 - 07/2008
6	Pharmaceutical PreparationsIBA 04/2021 - 06/2009
5	Biological ProductsIBA 01/2022 - 04/2014
4	Matrix Metalloproteinases (MMPs)IBA 07/2021 - 08/2006
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2017
3	thiazolyl blueIBA 03/2022 - 02/2020
3	Neuroprotective AgentsIBA 01/2021 - 01/2002
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2015 - 09/2003
3	NeurocalcinIBA 08/2011 - 09/2006
2	Indicators and Reagents (Reagents)IBA 03/2022 - 01/2016
2	Ether (Diethyl Ether)IBA 02/2022 - 02/2020
2	CalciumIBA 01/2022 - 01/2017
2	EnzymesIBA 01/2022 - 09/2003
2	SulfurIBA 10/2021 - 05/2021
2	dimethyl sulfone (methylsulfonylmethane)IBA 10/2021 - 05/2021
2	LipopolysaccharidesIBA 05/2021 - 01/2021
2	gingerolIBA 04/2021 - 01/2021
2	IronIBA 01/2021 - 01/2021
2	Serotonin (5 Hydroxytryptamine)IBA 11/2020 - 05/2014
2	Retinaldehyde (Retinal)IBA 10/2020 - 07/2013
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 09/2019 - 05/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2019 - 01/2002
2	CytokinesIBA 01/2019 - 06/2005
2	Small Interfering RNA (siRNA)IBA 09/2012 - 11/2005
2	splenotritin (TP3)IBA 01/2011 - 02/2003
1	2- (4- iodo- 2,5- dimethoxyphenyl)- N- (2- methoxybenzyl)ethanamineIBA 03/2022
1	Phosphotransferases (Kinase)IBA 03/2022
1	25C-NBOHIBA 02/2022
1	N- (2- hydroxybenzyl)- 2- (4- iodo- 2,5- dimethoxyphenyl)ethan- 1- aminiumIBA 02/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2022
1	FlavonoidsIBA 09/2021
1	nobiletinIBA 09/2021
1	tau Proteins (tau Protein)IBA 07/2021
1	Sulfur Compounds (Compounds, Sulfur)IBA 05/2021
1	MineralsIBA 05/2021
1	CosmeticsIBA 05/2021
1	Hormones (Hormone)IBA 04/2021
1	ErbB Receptors (EGF Receptor)IBA 04/2021
1	Ursolic AcidIBA 03/2021
1	Silybin (Lagosa)IBA 01/2021
1	Heme (Haem)IBA 01/2021
1	NucleotidesIBA 01/2021

Therapy/Procedure

18	Therapeutics 11/2021 - 01/2002
7	Thrombectomy 01/2021 - 01/2017
5	Thrombolytic Therapy 01/2021 - 01/2002
2	Immunotherapy 09/2021 - 01/2021
2	East Asian Traditional Medicine (Oriental Medicine) 09/2021 - 06/2009
2	Blood Transfusion (Blood Transfusions) 10/2019 - 01/2018
2	Carotid Endarterectomy 03/2014 - 01/2013
1	Splenectomy 01/2022
1	Activities of Daily Living (ADL) 01/2022